Thymosin Alpha-1
Mechanism
A 28-amino-acid peptide hormone. Modulates T-cell function, dendritic cell activity, and Th1/Th2 balance. Approved as a pharmaceutical (Zadaxin) in 35+ countries for chronic hepatitis B/C, immune deficiency, and cancer adjunct therapy.
Typical dose
1.6mg subcutaneous twice weekly (clinical). 800mcg-1.6mg per injection, 2-3 times weekly (research).
Cycle length
12-24 weeks; pulsed cycling per protocol
Form
Injectable (subcutaneous)
Thymosin Alpha-1 protocols
Deep dives on Thymosin Alpha-1
- The Wolverine Stack: BPC-157 + TB-500 Healing Protocol (2026 Guide)BPC-157 + TB-500 Wolverine Stack dosing, mechanism, evidence strength, side effects, and sourcing: the complete 2026 protocol guide with real citations.
- How to Reconstitute Peptides: Step-by-Step Dosing Guide (2026)Step-by-step guide to reconstituting peptides: diluent selection, concentration maths, injection technique, storage, and common mistakes with worked examples.
- BPC-157 vs TB-500: Complete Healing Stack Comparison (2026 Guide)BPC-157 vs TB-500: mechanisms, dosing protocols, injury-matching tables, and the Wolverine stack explained. Evidence-based comparison for research purposes only.
- BPC-157 Oral vs Injectable: Which Delivery Method Works? (2026 Guide)BPC-157 oral vs injectable decoded at the receptor level: VEGFR2-Akt-eNOS for systemic repair, NF-kB for gut mucosa. PubMed-cited mechanism deep-dive.
- Which Peptides Are Legal Again in 2026? The Full FDA ListComplete guide to the 14 peptides returning to legal compounding status in 2026 after RFK Jr.'s FDA reclassification announcement. Every compound explained.
- 7 Best Peptides for Injury Recovery (2026 Guide)The 7 best peptides for injury recovery ranked by evidence and practical use. Covers BPC-157, TB-500, the Wolverine Stack, GHK-Cu, CJC-1295/Ipamorelin, Thymosin Alpha-1, and KPV with protocols and stacking guidance.
- Thymosin Alpha-1 Complete Guide: The Immune-Modulating Peptide With 35-Country Approval (2026)Thymosin alpha-1 complete guide: mechanism, dosing protocols, cycling, sourcing, and the clinical evidence behind the most validated immune peptide.
- What the FDA Reclassification Actually Means for Peptide UsersLearn how to evaluate peptide suppliers, read a third-party COA, spot counterfeits, and verify lab testing quality after the 2026 FDA reclassification.
- BPC-157 and TB-500 Post-Surgery Recovery Protocol: When to Start, Dosing, and Cycle Length (2026)BPC-157 and TB-500 post-surgery recovery: when to start, dosing, cycle length, and what the evidence supports for accelerated soft-tissue healing.
- 6 Best Peptides for Anti-Ageing and Longevity (2026)The anti-ageing peptide consensus is wrong. We rank epitalon, MOTS-c, and GHK-Cu by what the primary literature actually proves vs what marketing narratives claim.
- Thymosin Alpha-1 Dosage Protocol: Clinical Dosing, Cycling, and Stacking (2026)Deep-dive into how thymosin alpha-1 activates TLR-2/TLR-9 and NFkB pathways to drive T-cell maturation, plus dosing protocols grounded in mechanism data.
- Thymosin Alpha-1 for Chronic Illness and Immune Support: Hepatitis, Cancer Adjunct, Autoimmune (2026)Thymosin alpha-1 for chronic illness: clinical trial evidence for hepatitis B, cancer adjuvant use, autoimmune conditions, HIV immune reconstitution, and safety data
Get the Pre-Protocol Checklist
Free checklist plus weekly protocols, research breakdowns, and tactical guides. No spam. Unsubscribe anytime.